Skip to content

Clinical trials

Phase 2 Graves Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graves Disease Phase: Phase 2 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20101
20142
20161
20191
20231
20242
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed5
Unknown status2
Active, not recruiting1
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Immunovant Sciences GmbH4
Biogen1
Dr Cipto Mangunkusumo General Hospital1
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1
Northwell Health1
Novartis Pharmaceuticals1
Odense University Hospital1
Sanofi1
Sun Yat-sen University1
Tourmaline Bio, Inc., a Novartis Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graves Disease16
Hyperthyroidism10
Graves Ophthalmopathy3
Thyroid Diseases2
Autoimmune Diseases1
Endocrine System Diseases1
Exophthalmos1
Eye Diseases1
Eye Diseases, Hereditary1
Immune System Diseases1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.